Omega Therapeutics, Inc.
(NASDAQ : OMGA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -5.66%158.450.0%$674.64m
AMGNAmgen, Inc. -0.12%250.901.5%$609.20m
GILDGilead Sciences, Inc. -0.36%66.091.0%$435.79m
VRTXVertex Pharmaceuticals, Inc. -0.91%300.231.9%$425.42m
REGNRegeneron Pharmaceuticals, Inc. -1.52%638.872.6%$370.34m
ILMNIllumina, Inc. -2.91%213.453.3%$316.80m
SNSSSunesis Pharmaceuticals, Inc. -0.24%4.090.7%$285.91m
NVAXNovavax, Inc. -7.63%39.6175.7%$262.91m
BIIBBiogen, Inc. -0.94%217.571.8%$197.75m
BNTXBioNTech SE -4.53%153.110.0%$147.14m
GOVXGeoVax Labs, Inc. -0.41%2.240.0%$118.42m
BMRNBioMarin Pharmaceutical, Inc. -0.10%94.944.2%$101.22m
CRSPCRISPR Therapeutics AG -4.83%72.190.6%$93.62m
MRTXMirati Therapeutics, Inc. -5.48%80.701.6%$89.58m
PACBPacific Biosciences of California, Inc. -5.25%7.586.2%$87.60m

Company Profile

Omega Therapeutics, Inc. engages in the development of DNA-sequence-targeting and mRNA-encoded therapeutics. It offers its product under the OMEGA platform. The company was founded by Noubar B. Afeyan and David Berry on July 13, 2016 and is headquartered in Cambridge, MA.